Medisch Centrum Leeuwarden B.V. — Clinical Trial Site

137 Registered trials

60 Currently recruiting

Organisation

Medisch Centrum Leeuwarden B.V.

Location

Leeuwarden, Netherlands

Identifier

ORG-100042953

Address

Thialfweg 44, 8441 PW, Netherlands

Departments

#2202; oncology
#2914:Cardiology
#3354:Cardiology
2609:Hart- en vaatcentrum
4903: Pulmonology
Afdeling Longziekten
Afdeling Reumatologie
Anesthesiologie
Cardiology
centrum voor longziekten
Department of Medical Oncology
Department of Surgery
Emergency Department
Gynaecology
Hart- en Vaatcentrum
Hemato-oncology
Hematology
ICU
Intensive Care
Internal Medicine
Internal Oncology
interne geneeskunde
Interventional Cardiology
Kindergeneeskunde
Long
Longgeneeskunde
Medical oncology
Medische Oncologie
N/A
NA
Nephrology
Neurology
Obstetrics & Gynecology
OCL
Oncologie
Oncologisch Centrum
Oncologisch Centrum Leeuwarden
Oncologisch Centrum Leeuwarden (OCL) and Internal Medicine - Hematology
Oncology
Oncology center Leeuwarden
orthopedics
Polikliniek en Dagcentrum OCL
Pulmonary diseases
Pulmonary Science
Pulmonology
Rheumatology
Surgery
Urologie
Ward (Internal Medicine)

Clinical trials at this site (137)

Search interface

Phase 3 Study of Belzutifan in Combination With Lenvatinib Versus Cabozantinib for Treatment of RCC Ended

2024-510620-39-00 Advanced RCC with clear cell component 5 2021-04-19
A phase 3 multicentre, randomized, prospective, open-label trial of Ibrutinib monotherapy versus fixed-duration Venetoclax plus Obinutuzumab… Ended

2022-500439-35-00 treatment-naive chronic lymphocytic leukemia 5 2021-02-11
A Clinical trial to compare the combination of Isatuximab-Carfilzomib-Lenalidomide-Dexamethasone versus the combination of Carfilzomib-Lenal… Ended

2024-513422-38-00 Newly diagnosed multiple myeloma 5 2020-09-28
An open-label clinical trial evaluating enfortumab vedotin in combination with pembrolizumab versus chemotherapy alone in previously untreat… Ended

2023-503421-19-00 Urothelial cancer 5 2020-08-26
Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteremia (SAFE-trial) Ended

2024-515398-90-01 Staphylococcus aureus bacteremia 5 2020-08-17
HOVON 156 AML: Treatment for acute myeloid leukemia (AML) or myelodysplastic syndrome with a FLT3 mutation with gilteritinib or midostaurin … Ended

2022-502478-18-00 Acute Myeloid Leukemia (AML) 4 2019-12-20
A randomized phase II multicenter study to assess the tolerability and efficacy of the addition of midostaurin to 10-day decitabine in unfit… Ended

2023-503829-18-00 Acute myeloid leukemia 4 2019-12-05
EORTC-1537-LYMG: Very early FDG-PET-response adapted targeted therapy for advanced Hodgkin lymphoma: a single-arm phase II study Ended

2023-508478-27-00 Advanced stage Hodgkin Lymphoma 4 2019-07-30
Liposomal iRInotecan, Carboplatin or oXaliplatin in the first line treatment of esophagogastric cancer: a randomized phase 2 study (LyRICX) Ended

2023-509287-26-00 previously untreated metastatic or locally advanced eso 4 2019-07-01
Image‐guided de‐escalation of neoadjuvant chemotherapy in HER2‐positive breast cancer: the TRAIN‐3 study Ended

2024-516205-23-00 Breast cancer 4 2019-04-09
Treatment for previously untreated patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) with an IDH1 or IDH2 mutatio… Ended

2022-502832-37-00 Acute myeloid leukemia 5 2019-03-01
Treatment with carfilzomib, lenalidomide and dexamethasone versus lenalidomide and dexamethasone in patients with high-risk smoldering Multi… Ended

2024-511334-12-00 Smoldering Multiple Myeloma 4 2018-11-19
HOVON 151 DLBCL: A phase II study evaluating the feasibility and clinical efficacy of atezolizumab consolidation treatment in high risk diff… Ended

2022-501076-26-00 high risk diffuse large B-cell lymphoma 4 2018-08-28
HOVON 152 DLBCL. A phase II study evaluating the effect of DA-EPOCH-R induction followed by nivolumab consolidation in patients with newly d… Ended

2022-501038-48-00 Diffuse Large B-Cell Lymphoma 4 2018-07-26
Endocrine therapy plus CDK 4/6 inhibition in first- or second-line for hormone receptor positive advanced breast cancer - the SONIA study Ended

2024-516204-42-00 Breast cancer 5 2017-11-21
CRITICS-II Ended

2023-503248-15-00 Patients with TNM 8th ed stage IB-IIC gastric adenocaci 4 2017-10-09
Treatment of peritoneal dissemination in stomach cancer patients with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy; P… Ended

2023-510159-53-01 peritoneal dissemination in stomach cancer patients 4 2017-09-28
STAR-TREC: Can we Save the rectum by watchful waiting or TransAnal surgery following (chemo)Radiotherapy versus Total mesorectal excision fo… Ended

2024-516106-31-00 Early stage colorectal cancer 10 2017-06-16
Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP) Ended

2023-507889-89-00 Respiratory tract infection 5 2016-02-19
Biomarker discovery randomized phase IIb trial with carboplatin-cyclophosphamide versus paclitaxel with or without atezolizumaB as first-lin… Ended

2024-516202-39-00 Metastatic breast cancer 4 2013-10-10
PUMP-IT RCT: Hepatic arterial infusion PUMP chemotherapy combined with systemic therapy versus systemic therapy alone as Induction Therapy f… Halted

2023-506194-35-00 Colorectal liver metastases 5 2024-11-21
Study of efficacy and safety of JDQ443 single-agent as first-line treatment for patients with locally advanced or metastatic KRAS G12C- muta… Halted

2024-511708-18-00 Locally advanced or metastatic KRAS G12C-mutated non-sm 4 2022-12-06
WOMEN&More: Efficacy, safety, and acceptability of mifepristone 50 mg once-weekly as a contraceptive Ended

2022-502694-41-00 Contraception 5 2025-04-14
A proof of concept and dose-finding study of XXB750 in patients with heart failure Ended

2023-504678-39-00 Heart Failure 4 2024-03-13